This ZDNet article confirms what we already know–the pace of development and bringing to market of remote monitoring in telecare and telehealth is increasing (building to a critical mass?), but insurance company reimbursement and FDA approvals are not keeping up. The overview starts with the Alcatel-Lucent FDA approval (covered below) and others including Medtronics, MedApps, St. Jude Medical, ExpressMD and Biotronik. (One small absurdity: the proposal that Intel and GE lead the industry in streamlining approvals by both insurance companies and the FDA.)
More evidence of mainstreaming: the TechZulu website is not known for covering healthcare but here’s an article and show floor video (your Friday ‘funny’) about MedApps at CTIA.
[Clueless interviewer manages to ask all the right questions!]